Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis

Summary

The study will test the safety and tolerability of Apremilast twice a day in participants with recalcitrant plaque type psoriasis.

Timeline

Start

2007-08-01

Primary completion

2009-04-01

Completion

2009-05-01

Publications

• Results Gottlieb AB, Matheson RT, Menter A, Leonardi CL, Day RM, Hu C, Schafer PH, Krueger JG. Efficacy, tolerability, and pharmacodynamics of apremilast in recalcitrant plaque psoriasis: a phase II open-label study. J Drugs Dermatol. 2013 Aug;12(8):888-97.

Drugs

Indications